Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Grand Brilliance Group Holdings Days Payable?
Grand Brilliance Group HoldingsHKSE:08372 66 Days Payable is 84.32 as of Mar. 2026, which is 30% above its 10-year median of 64.89. GuruFocus rates HKSE:08372 with a GF Score™ of 66/100 and a GF Value™ of HK$0.12 (Fairly Valued). The stock has 5 warning signs investors should review. Among 117 Medical Distribution companies, Grand Brilliance Group Holdings ranks worse than 56.41% on this metric.
The historical rank and industry rank for Grand Brilliance Group Holdings's Days Payable or its related term are showing as below:
HKSE:08372'
s Days Payable Range Over the Past 10 Years
Min: 44.2 Med: 64.89 Max: 96.85
Current: 66.03
During the past 11 years, Grand Brilliance Group Holdings's highest Days Payable was 96.85. The lowest was 44.20. And the median was 64.89.
HKSE:08372's Days Payable is ranked worse than 56.41% of 117
companies
in the Medical Distribution industry
Industry Median: 76.42
vs HKSE:08372: 66.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Brilliance Group Holdings Days Payable Chart
HKSE:08372 vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, Grand Brilliance Group Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Brilliance Group Holdings Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Grand Brilliance Group Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Grand Brilliance Group Holdings's Days Payable falls into.
Grand Brilliance Group Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Brilliance Group Holdings (HKSE:08372) has a Days Payable of 84.32 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Grand Brilliance Group Holdings and its competitors. This is 30% above median its historical median of 64.89. Over the past decade, Grand Brilliance Group Holdings' Days Payable has ranged from 44.20 to 96.85. According to the industry distribution chart, Grand Brilliance Group Holdings ranks #66 out of 117 companies in the Medical Distribution industry, placing it in the top 56.4%.
Is Grand Brilliance Group Holdings' Days Payable too high?
Grand Brilliance Group Holdings' current Days Payable of 84.32 is 30% above median its 10-year median of 64.89. Over the past 10 years, this metric has ranged from a low of 44.20 to a high of 96.85. The Medical Distribution industry median Days Payable is 76.42. Grand Brilliance Group Holdings' value of 84.32 is 10.3% above this industry median. Based on the distribution chart, Grand Brilliance Group Holdings ranks #66 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Grand Brilliance Group Holdings has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Grand Brilliance Group Holdings' Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Grand Brilliance Group Holdings ranks #66 out of 117 companies for Days Payable. This places Grand Brilliance Group Holdings in the lower half of its industry. The industry median Days Payable is 76.42. Grand Brilliance Group Holdings' value of 84.32 is 10.3% above this benchmark. Historically, Grand Brilliance Group Holdings' own Days Payable has ranged from 44.20 to 96.85 over the past decade. While the company's 10-year median is 64.89 vs. the industry median of 76.42, Grand Brilliance Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 76.42, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grand Brilliance Group Holdings's current Days Payable of 84.32 is 10.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Grand Brilliance Group Holdings and its competitors. For the Medical Distribution industry, the median Days Payable is 76.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Brilliance Group Holdings's current Days Payable is 84.32, which is 30% above median its own 10-year median of 64.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Brilliance Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings (HKSE:08372) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.12, compared to a current price of HK$0.13 — trading 5.8% above its estimated fair value. The current Days Payable is 84.32, which is 30% above median its 10-year median of 64.89 and 10.3% above the Medical Distribution industry median of 76.42. Grand Brilliance Group Holdings' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Grand Brilliance Group Holdings (HKSE:08372), the current Days Payable is 84.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grand Brilliance Group Holdings (HKSE:08372) Overvalued in 2026?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings stock appears to be overvalued.
The current stock price of HK$0.13 is trading 5.8% above its estimated GF Value™ of HK$0.12.
GuruFocus considers Grand Brilliance Group Holdings to be Fairly Valued.
Key valuation signals for HKSE:08372:
Days Payable: 84.32 (30% above median its 10-year median of 64.89)
GF Value™: HK$0.12 vs. price of HK$0.13 (5.8% above fair value)
Industry Position: 10.3% above the Medical Distribution median (#66 of 117)
No single metric tells the full story. See the HKSE:08372 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. It serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
66GF Score
Get the complete analysis for HKSE:08372
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08372 has been successfully added to your 
